RVMDW Revolution Medicines, Inc. Warr
$11.29▲ +2.08%
Unknown
Other
Volume 14.9K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
10.60 - 11.30
% vs 50 MA
20.78%
% vs 200 MA
–%
RSI-14
51.8
MACD Histogram
-0.3100
Beta (1Y vs SPY)
-5.79
Free Cash Flow
-$745.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$460.52M
COGS
–
Operating Exp
$505.13M
Operating Income
-$505.13M
EBIT
-$505.13M
Pretax Income
-$644.37M
Net Income
-$644.37M
Price & Volume History
Loading chart…
Recent News
Revolution Medicines (RVMD) Gets its First Approved Drug, and the Market Shrugs
Insider Monkey · Sep 12, 2026 12:40 AM
WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338
PR Newswire · Sep 11, 2026 6:00 PM
Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338
ACCESS Newswire · Sep 11, 2026 5:22 PM
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 3:49 PM
Revolution Medicines Insider Sold Shares Worth $3,585,837, According to a Recent SEC Filing
MT Newswires · Sep 10, 2026 9:59 PM
Revolution Medicines Got a ‘Miracle’ Cancer Drug Approval. Wall Street Wants More.
Barrons.com · Sep 10, 2026 6:40 PM
Revolution Medicines to Gain From Drug Expansion, New Combination Therapies, Morgan Stanley Says
MT Newswires · Sep 10, 2026 3:29 PM
Update: Morgan Stanley Initiates Revolution Medicines With Overweight Rating, $255 Price Target
MT Newswires · Sep 10, 2026 11:57 AM
Morgan Stanley Initiates Coverage on Revolution Medicines With Overweight Rating
MT Newswires · Sep 10, 2026 11:33 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RVMDW's money flow as a full page
Social Sentiment
No Reddit posts found for RVMDW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.